2023
DOI: 10.1016/j.tips.2023.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Copper homeostasis and cuproptosis in cardiovascular disease therapeutics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(11 citation statements)
references
References 97 publications
0
10
0
Order By: Relevance
“… 57 Recent studies have also highlighted the role of Cu homeostasis and cuproptosis, a novel form of regulated cell death, in the development and progression of CVDs. 58 VC is a complex cellular and molecular process, involving the osteochondrogenic transformation of VSMCs, the disturbance of Ca‐phosphate metabolism, inflammation and oxidative stress. 4 Abnormal levels of Cu may cause oxidative stress and inflammatory responses, which may accelerate the progression of VC, but the specific mechanisms are not clear.…”
Section: Discussionmentioning
confidence: 99%
“… 57 Recent studies have also highlighted the role of Cu homeostasis and cuproptosis, a novel form of regulated cell death, in the development and progression of CVDs. 58 VC is a complex cellular and molecular process, involving the osteochondrogenic transformation of VSMCs, the disturbance of Ca‐phosphate metabolism, inflammation and oxidative stress. 4 Abnormal levels of Cu may cause oxidative stress and inflammatory responses, which may accelerate the progression of VC, but the specific mechanisms are not clear.…”
Section: Discussionmentioning
confidence: 99%
“…Copper binds with albumin and ceruloplasmin in the liver and is carried throughout the body via the bloodstream. 80 Copper is vital for maintaining essential cellular functions, as well as involving antioxidant reactions, maintaining cell membrane and DNA integrity, and aiding in ATP production. 81 …”
Section: The Role Of Essential Trace Elementsmentioning
confidence: 99%
“…Cuproptosis, a distinctive cell death mechanism, has generated significant interest in cancer research due to its potential in novel therapeutic approaches, including inhibiting tumor cell proliferation and possibly reversing cancer drug resistance, akin to ferroptosis [ 195 198 ]. Emerging compounds have shown the ability to induce cuproptosis in preclinical models.…”
Section: Introductionmentioning
confidence: 99%
“…Emerging compounds have shown the ability to induce cuproptosis in preclinical models. Specifically, the downregulation of FDX1, DLAT, SDHB (succinate dehydrogenase complex, subunit B), and DLST (dihydrolipoamide S-succinyltransferase) genes in primary CRC tissues suggests a link to disease progression, with higher expression of these genes correlating to better prognosis [ 195 198 ]. ES-Cu treatment notably reduces cell viability in CRC cells.…”
Section: Introductionmentioning
confidence: 99%